Previous studies have shown that vitamin D (its bioactive form 1α,25(OH)2D3) and the vitamin D receptor (VDR) are involved in the development of T2D, suggesting a potential therapeutic role for vitamin D in diabetes 5-8. This evidence concerns the gene VDR and diabetes mellitus.